Rebecca Nicolai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rebecca Nicolai has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alessandra Boni
Division of Rheumatology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
1 shared publication- Claudia Bracaglia
Division of Rheumatology, ERN-RITA center IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
1 shared publication - Emiliano Marasco
Division of Rheumatology, Bambino Gesù Children’s Hospital, 00165 Rome, Italy
1 shared publication Fabrizio De Benedetti
Division of Rheumatology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
1 shared publicationGian Marco Moneta
Laboratory of Immuno-Rheumatology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
1 shared publicationIvan Caiello
Laboratory of Immuno-Rheumatology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 4 November 2024
- Published by SAGE Publications in Lupus
- Vol. 33 (14) , 1594-1604
Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome
Objective: to investigate the trend of autoantibody titers during a 2-year follow-up in pediatric systemic lupus erythematosus (pSLE) and pediatric Sjögren's syndrome (pSS). Methods: Autoantibodies testing was performed every 3-4 months during 2 years from disease onset in a cohort of children with pSLE and pSS. Results: We enrolled 21 children with pSLE and 22 children with pSS. All pSLE patients at 2 years showed ANA titers significantly lower compared to disease onset. Eleven patients (73%) were still ANA positive at 2 years, while 4 (26%) became ANA negative. At diagnosis, 12 (80%) patients showed a homogeneous pattern, while 3 (20%) patients showed a speckled pattern. The latter remained ANA positive with the same pattern; only 2 patients with a homogenous pattern converted to speckled, 4 patients with a homogeneous pattern became ANA negative. ANA negative pSLE patients showed lower levels of interferon score compared to ANA positive patients. Anti-dsDNA titers declined equally in the two groups. All patients with pSS, at disease onset, were ANA and anti-Ro positive and 14 (66%) were anti-La positive. After 2 years of follow-up, 100% remained ANA positive but showed significant lower titers. During follow-up anti-Ro and anti-La titers remained stable. Conclusion: different patterns in changes of ANA and ENA titers in pSLE and pSS were shown. At 2 years of follow-up, all pSLE patients had a lower ANA titer and 26% became negative; however, all pSS patients remained both ANA and ENA positive. This evidence may be due to different pathogenetic pathways in SLE and pSS.
- 4 November 2024
- Published by SAGE Publications in Lupus
- Vol. 33 (14) , 1594-1604
Open AccessDifferent patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome
Objective: to investigate the trend of autoantibody titers during a 2-year follow-up in pediatric systemic lupus erythematosus (pSLE) and pediatric Sjögren's syndrome (pSS). Methods: Autoantibodies testing was performed every 3-4 months during 2 years from disease onset in a cohort of children with pSLE and pSS. Results: We enrolled 21 children with pSLE and 22 children with pSS. All pSLE patients at 2 years showed ANA titers significantly lower compared to disease onset. Eleven patients (73%) were still ANA positive at 2 years, while 4 (26%) became ANA negative. At diagnosis, 12 (80%) patients showed a homogeneous pattern, while 3 (20%) patients showed a speckled pattern. The latter remained ANA positive with the same pattern; only 2 patients with a homogenous pattern converted to speckled, 4 patients with a homogeneous pattern became ANA negative. ANA negative pSLE patients showed lower levels of interferon score compared to ANA positive patients. Anti-dsDNA titers declined equally in the two groups. All patients with pSS, at disease onset, were ANA and anti-Ro positive and 14 (66%) were anti-La positive. After 2 years of follow-up, 100% remained ANA positive but showed significant lower titers. During follow-up anti-Ro and anti-La titers remained stable. Conclusion: different patterns in changes of ANA and ENA titers in pSLE and pSS were shown. At 2 years of follow-up, all pSLE patients had a lower ANA titer and 26% became negative; however, all pSS patients remained both ANA and ENA positive. This evidence may be due to different pathogenetic pathways in SLE and pSS.